MML Investors Services LLC lifted its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 21.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 5,382 shares of the medical research company’s stock after acquiring an additional 948 shares during the quarter. MML Investors Services LLC’s holdings in Thermo Fisher Scientific were worth $1,022,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also modified their holdings of TMO. Icon Wealth Partners LLC bought a new position in shares of Thermo Fisher Scientific during the 4th quarter worth approximately $105,000. Bank of Nova Scotia Trust Co. bought a new position in shares of Thermo Fisher Scientific during the 3rd quarter worth approximately $106,000. Keeler Thomas Management LLC bought a new position in shares of Thermo Fisher Scientific during the 4th quarter worth approximately $106,000. SeaCrest Wealth Management LLC bought a new position in shares of Thermo Fisher Scientific during the 4th quarter worth approximately $195,000. Finally, Csenge Advisory Group bought a new position in shares of Thermo Fisher Scientific during the 3rd quarter worth approximately $201,000. Institutional investors own 87.67% of the company’s stock.
Shares of Thermo Fisher Scientific Inc. (TMO) opened at $215.12 on Wednesday. The firm has a market capitalization of $86,260.00, a price-to-earnings ratio of 35.21, a PEG ratio of 1.60 and a beta of 1.15. The company has a current ratio of 1.34, a quick ratio of 0.92 and a debt-to-equity ratio of 0.74. Thermo Fisher Scientific Inc. has a 1 year low of $151.74 and a 1 year high of $226.44.
The business also recently announced a quarterly dividend, which will be paid on Monday, April 16th. Stockholders of record on Thursday, March 15th will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.32%. This is an increase from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. The ex-dividend date is Wednesday, March 14th. Thermo Fisher Scientific’s dividend payout ratio is presently 9.82%.
In other news, CEO Marc N. Casper sold 50,000 shares of the business’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $191.74, for a total transaction of $9,587,000.00. Following the completion of the transaction, the chief executive officer now owns 302,577 shares of the company’s stock, valued at approximately $58,016,113.98. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Stephen Williamson sold 2,500 shares of the business’s stock in a transaction on Monday, March 5th. The stock was sold at an average price of $204.60, for a total value of $511,500.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 98,827 shares of company stock valued at $20,193,272. Corporate insiders own 0.49% of the company’s stock.
Several analysts recently issued reports on TMO shares. ValuEngine upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Zacks Investment Research upgraded Thermo Fisher Scientific from a “sell” rating to a “hold” rating in a research note on Saturday, January 20th. Morgan Stanley boosted their price target on Thermo Fisher Scientific from $223.00 to $227.00 and gave the company an “overweight” rating in a research note on Thursday, February 1st. BTIG Research started coverage on Thermo Fisher Scientific in a research note on Friday, January 5th. They issued a “buy” rating and a $230.00 price target for the company. Finally, Evercore ISI started coverage on Thermo Fisher Scientific in a research note on Wednesday, January 3rd. They issued an “outperform” rating and a $220.00 price target for the company. Two research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Thermo Fisher Scientific has a consensus rating of “Buy” and an average price target of $220.50.
WARNING: This piece was originally reported by Markets Daily and is the sole property of of Markets Daily. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.themarketsdaily.com/2018/03/14/thermo-fisher-scientific-inc-tmo-shares-bought-by-mml-investors-services-llc.html.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.